Form D · Hedge Fund

OrbiMed Global Healthcare Fund, L.P.

New York, NY · CIK 0001613540

Offering snapshot reported Jul 16, 2021 · SEC filing

Reported sold
$113M
Indefinite offering
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 16, 2021Amendment$113,350,000No comparisonNot reportedSEC filing
Jul 16, 2020Amendment$113,350,000$0vs Jul 16, 201910SEC filing
Jul 16, 2019Amendment$113,350,000$0vs Jul 16, 201810SEC filing
Jul 16, 2018Amendment$113,350,000$107,350,000vs Jul 14, 201410SEC filing
Jul 14, 2017Amendment$113,350,000$107,350,000vs Jul 14, 201410SEC filing
Jul 14, 2016Amendment$113,350,000$107,350,000vs Jul 14, 201410SEC filing
Jul 14, 2015Amendment$11,250,000$5,250,000vs Jul 14, 20147SEC filing
Jul 14, 2014Initial$6,000,000No comparison2SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-220964

Source: Form D, filed Jul 16, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ORBIMED GLOBAL HEALTHCARE FUND, LP

Investment adviser: ORBIMED ADVISORS LLC

Gross asset value
Not reported
Beneficial owners
Not reported
ADV minimum commitment
Not reported

Reported in Form ADV on Feb 28, 2023. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

No provider names available in this fund's imported disclosure.

Provider details
Annual audit
Not reported
Prime brokers
Not reported
Custodians
Not reported
Administrator other than the adviser
Not reported
External marketing
Not reported
Filing source

Form ADV 1720806 · Feb 28, 2023 · Schedule D 7.B.(1), fund 805-2942252816

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David Bonita Executive
Sven H. Borho Executive
Carl L. Gordon Executive
Geoffrey C. Hsu Executive
Samuel D. Isaly Executive
W. Carter Neild Executive
Orbi Med Advisors Llc Executive, Promoter
Orbi Med Global Healthcare Gp Llc Executive
Jonathan T. Silverstein Executive
C. Scotland Stevens Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
601 Lexington Avenue, 54 Th Floor
New York, NY, 10022